SeaSpine's latest commercial launch and three other updates from spine devicemakers Becker's has covered since June 22:
1. Medtronic received FDA 510(k) clearance and breakthrough device designation for its LigaPass 2.0 ligament augmentation system.
2. The FDA gave an investigational device exemption to devicemaker 3Spine.
3. SeaSpine released its WaveForm C interbody system in a full commercial launch.
3. Medtronic named Lidia Fonseca as an independent director of its board of directors.